1. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. (12th September 2018) Authors: Frodlund, M; Vikerfors, A; Grosso, G; Skogh, T; Wetterö, J; Elvin, K; Gunnarsson, I; Kastbom, A; Dahlström, Ö; Rönnelid, J; Svenungsson, E; Sjöwall, C Journal: Clinical and experimental immunology Issue: Volume 194:Number 1(2018:Oct.) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease. (19th December 2019) Authors: Frodlund, M; Wetterö, J; Dahle, C; Dahlström, Ö; Skogh, T; Rönnelid, J; Sjöwall, C Journal: Clinical and experimental immunology Issue: Volume 199:Number 3(2020) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO.4.94 High B-cell polygenic risk is associated with dsDNA antibodies and nephritis in systemic lupus erythematosus. (27th September 2022) Authors: Hedenstedt, A; Reid, S; Sayadi, A; Eloranta, M; Skoglund, E; Bolin, K; Frodlund, M; Lerang, K; Jönsen, A; Rantapää-Dahlqvist, S; Bengtsson, A; Rudin, A; Molberg, Ø; Sjöwall, C; Rönnblom, L; Sandling, J; Leonard, D Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PS4:71 Iga anti-phospholipid antibodies in swedish cases with systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. (21st March 2018) Authors: Frodlund, M; Vikerfors, A; Grosso, G; Skogh, T; Wetterö, J; Elvin, K; Gunnarsson, I; Kastbom, A; Dahlström, Ö; Rönnelid, J; Svenungsson, E; Sjöwall, C Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PS7:132 Smoking reduces the efficacy of belimumab in mucocutaneous lupus. (21st March 2018) Authors: Parodis, I; Gomez, A; Sjöwall, C; Jönsen, A; Zickert, A; Frodlund, M; Bengtsson, AA; Gunnarsson, I Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S10.2 Interaction between HLA-DRB1*03:01 and stat4 is associated with increased risk of nephritis in systemic lupus erythematosus. (27th September 2022) Authors: Lundqvist, E; Reid, S; Sayadi, A; Eloranta, M; Skoglund, E; Bolin, K; Frodlund, M; Lerang, K; Jönsen, A; Rantapää-Dahlqvist, S; Bengtsson A, A; Rudin, A; Molberg, Ø; Sjöwall, C; Sandling J, K; Rönnblom, L; Leonard, D Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S4A:5 High genetic risk score is associated with organ damage in systemic lupus erythematosus. (21st March 2018) Authors: Reid, S; Alexsson, A; Frodlund, M; Svenungsson, E; Sandling, JK; Jönsen, A; Bengtsson, C; Gunnarsson, I; Bengtsson, A; Rantapää-Dahlqvist, S; Syvänen, A-C; Sjöwal, C; Rönnblom, L; Leonard, D Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0233 High anti-dsdna content in sle immune complexes is associated with clinical remission following belimumab treatment. (15th June 2017) Authors: Sohrabian, A; Parodis, I; Carlströmer-Berthén, N; Sjöwall, C; Jönsen, A; Zickert, A; Frodlund, M; Bengtsson, A; Gunnarsson, I; Rönnelid, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts. (September 2019) Authors: Frodlund, M; Reid, S; Wetterö, J; Dahlström, Ö; Sjöwall, C; Leonard, D Journal: Lupus Issue: Volume 28:Number 10(2019) Page Start: 1261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗